Skip to main content
. 2022 Oct 20;13:1166–1173. doi: 10.18632/oncotarget.28299

Table 1. Clinico-pathological characteristics and Nectin-4 expression.

Bonn HNSCC cohort
Total Nectin-4 negative Low Nectin-4 Medium Nectin-4 High Nectin-4 p-value*
All HNSCC cases n = 159 22 (13.8%) 85 (53.5%) 43 (27.0%) 9 (5.7%)
Patients with clinical data n = 151
Normal tissue n = 28 1 (3.6%) 8 (28.6%) 19 (67.9%) 0 (0%)
Gender
 Male 126 (83.4%) 13 66 38 9 0.0101
 Female 25 (16.6%) 5 17 3 9
Age [mean, standard deviation] 64.4 [9.6] 65.27 [11.84] 64.16 [9.60] 64.45 [10.10] 64.17 [5.19]
Localization
 Oral cavity 8 (7.8%) 1 5 0 2 0.9922
 Oropharynx 59 (57.8%) 8 29 18 4
 Hypopharynx 7 (6.8%) 0 5 2 0
 Larynx 28 (27.2%) 2 17 9 0
 Unknown 49
Tobacco consumption
 Non-smokers 6 (12.5%) 0 0 4 2 0.0011
 Smokers 42 (87.5%) 2 27 13 0
 Unknown 111
Alcohol consumption
 No alcohol 2 (4.5%) 0 2 0 0 0.0672
 Occasional 28 (63.6%) 1 14 12 1
 Frequent 14 (31.8%) 1 9 3 1
 Unknown 115
HPV status (p16)
 p16 negative 117 (73.6%) 19 67 26 5 0.0051
 p16 positive 42 (26.4%) 3 18 17 4
T-stage
 pTis 1 (0.7%) 0 1 0 0 0.4442
 pT1 26 (18.6%) 2 17 5 2
 pT2 56 (40.0%) 7 27 19 3
 pT3 35 (25.0%) 6 22 5 2
 pT4 22 (15.7%) 2 11 8 1
 Unknown 19
Lymph node involvement
 pN0 54 (41.9%) 9 29 14 2 0.5802
 pN1 19 (14.7%) 1 10 8 0
 pN2 53 (41.1%) 7 28 13 5
 pN3 3 (2.3%) 0 3 0 0
 Unknown 29
Distant metastases
 M0 70 (98.6%) 7 42 18 3 0.6951
 M1 1 (1.4%) 0 1 0 0
 Unknown 88
Grading
 G1 3 (2.2%) 0 1 2 0 0.5452
 G2 78 (56.5%) 8 46 18 6
 G3 57 (41.3%) 8 29 17 3
 Unknown 21

1Mann–Whitney U test. 2Kruskal-Wallis-test. *all Nectin-4 expression categories (negative, low, medium and high) included.